Verrica Pharmaceuticals Inc. Gain (Loss) on Disposition of Property Plant Equipment, Excluding Oil and Gas Property and Timber Property
Verrica Pharmaceuticals Inc. (VRCA) reported Gain (Loss) on Disposition of Property Plant Equipment, Excluding Oil and Gas Property and Timber Property of $0 for the 6-month period ending 2026-06-30, per its 10-Q filed 2026-08-06.
Financial Statements › Income Statement › Other Income
us-gaap:GainLossOnDispositionOfAssets · last filed 2026-08-06
- Verrica Pharmaceuticals Inc. gain (loss) on disposition of property plant equipment, excluding oil and gas property and timber property for the quarter ending 2025-12-31 was $0.00, a 100.00% decline year-over-year.
- Verrica Pharmaceuticals Inc. gain (loss) on disposition of property plant equipment, excluding oil and gas property and timber property for the quarter ending 2025-09-30 was -$68.00K.
- Verrica Pharmaceuticals Inc. gain (loss) on disposition of property plant equipment, excluding oil and gas property and timber property for the quarter ending 2024-12-31 was $58.00K.
- Verrica Pharmaceuticals Inc. gain (loss) on disposition of property plant equipment, excluding oil and gas property and timber property for the quarter ending 2024-09-30 was $0.00.
- Verrica Pharmaceuticals Inc. gain (loss) on disposition of property plant equipment, excluding oil and gas property and timber property for fiscal 2025 was -$246.00K.
- Verrica Pharmaceuticals Inc. gain (loss) on disposition of property plant equipment, excluding oil and gas property and timber property for fiscal 2024 was -$83.00K.
- Verrica Pharmaceuticals Inc. gain (loss) on disposition of property plant equipment, excluding oil and gas property and timber property for fiscal 2023 was -$2.54M.
- Verrica Pharmaceuticals Inc. gain (loss) on disposition of property plant equipment, excluding oil and gas property and timber property for fiscal 2022 was $0.00.
| Period end | Gain (Loss) on Disposition of Property Plant Equipment, Excluding Oil and Gas Property and Timber Property 3 month | Gain (Loss) on Disposition of Property Plant Equipment, Excluding Oil and Gas Property and Timber Property 6 month | Gain (Loss) on Disposition of Property Plant Equipment, Excluding Oil and Gas Property and Timber Property 9 month | Gain (Loss) on Disposition of Property Plant Equipment, Excluding Oil and Gas Property and Timber Property 12 month |
|---|---|---|---|---|
| 2026-06-30 | $0.00 10-Q · filed 2026-08-06 | |||
| 2025-12-31 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2026-03-11 | -$68.00K derived: sum of 2 quarters · filed 2026-03-11 | -$246.00K 10-K · filed 2026-03-11 | |
| 2025-09-30 | -$68.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2025-11-14 | -$246.00K 10-Q · filed 2025-11-14 | ||
| 2025-06-30 | -$178.00K 10-Q · filed 2026-08-06 | |||
| 2024-12-31 | $58.00K derived: 10-K 12 month − 10-Q 9 month · filed 2026-03-11 | $58.00K derived: sum of 2 quarters · filed 2026-03-11 | -$83.00K 10-K · filed 2026-03-11 | |
| 2024-09-30 | $0.00 derived: 10-Q 9 month − 10-Q 6 month · filed 2025-11-14 | -$141.00K 10-Q · filed 2025-11-14 | ||
| 2024-06-30 | -$141.00K 10-Q · filed 2025-08-12 | |||
| 2023-12-31 | -$2.48M derived: 10-K 12 month − 10-Q 9 month · filed 2025-03-11 | -$2.54M derived: sum of 2 quarters · filed 2025-03-11 | -$2.54M 10-K · filed 2025-03-11 | |
| 2023-09-30 | -$61.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2024-11-05 | -$61.00K 10-Q · filed 2024-11-05 | ||
| 2023-06-30 | $0.00 10-Q · filed 2024-08-14 | |||
| 2022-12-31 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2024-02-29 | $0.00 10-K · filed 2024-02-29 | ||
| 2022-09-30 | $0.00 10-Q · filed 2023-11-09 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| OS Therapies Inc (OSTX) | United States | $0.076B | -2.17 |
| iBio, Inc. (IBIO) | United States | $0.077B | -2.94 |
| MAIA Biotechnology, Inc. (MAIA) | United States | $0.077B | -2.30 |
| Valion Bio, Inc. (VBIO) | United States | $0.077B | |
| Adicet Bio, Inc. (ACET) | United States | $0.078B | -0.81 |
| Lifevantage Corp (LFVN) | United States | $0.078B | 15.40 |
| Aldeyra Therapeutics, Inc. (ALDX) | United States | $0.074B | -5.57 |
| Cingulate Inc. (CING) | United States | $0.073B | -2.64 |
| Spero Therapeutics, Inc. (SPRO) | United States | $0.073B | 17.41 |
| Gain Therapeutics, Inc. (GANX) | United States | $0.080B | -4.40 |